Join the iTeos Team

Our Corporate Culture

Michel Detheux, Ph.D.

Core to our strategy is continuing to build a team and company culture that prioritizes patient needs as we develop our lead programs and pipeline assets by applying our deep expertise in understanding of the tumor microenvironment to the discovery and development of novel immuno-oncology therapies that have the potential to provide breakthroughs for patients. Our presence in Cambridge, Massachusetts and Belgium is a strategic advantage that enhances our ability to attract global talent and remain at the forefront of innovation in the field of immuno-oncology.

Michel Detheux, Ph.D. Co-founder & CEO